{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:45:03Z","timestamp":1791564303964,"version":"4.3.4"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022664","name":"Universidad de Le\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study sought to investigate whether applying an adapted person-centered prescription (PCP) model reduces the total regular medications in older people admitted in a subacute hospital at the end of life (EOL), improving pharmacotherapeutic indicators and reducing the expense associated with pharmacological treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Randomized controlled trial. The trial was registered with ClinicalTrials.gov (NCT05454644).<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>A subacute hospital in Basque Country, Spain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Subjects<\/jats:title><jats:p>Adults \u226565 years (<jats:italic>n<\/jats:italic> = 114) who were admitted to a geriatric convalescence unit and required palliative care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>The adapted PCP model consisted of a systematic four-step process conducted by geriatricians and clinical pharmacists. Relative to the original model, this adapted model entails a protocol for the tools and assessments to be conducted on people identified as being at the EOL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements<\/jats:title><jats:p>After applying the adapted PCP model, the mean change in the number of regular drugs, STOPPFrail (Screening Tool of Older Persons' Prescriptions in Frail adults with limited life expectancy) criteria, drug burden index (DBI), drug\u2013drug interactions, medication regimen complexity index (MRCI) and 28-days medication cost of chronic prescriptions between admission and discharge was analyzed. All patients were followed for 3 months after hospital discharge to measure the intervention's effectiveness over time on pharmacotherapeutic variables and the cost of chronic medical prescriptions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The number of regular prescribed medications at baseline was 9.0 \u00b1 3.2 in the intervention group and 8.2 \u00b1 3.5 in the control group. The mean change in the number of regular prescriptions at discharge was \u22121.74 in the intervention group and \u22120.07 in the control group (mean difference = 1.67 \u00b1 0.57; <jats:italic>p<\/jats:italic> = 0.007). Applying a PCP model reduced all measured criteria compared with pre-admission (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). At discharge, the mean change in 28-days medication cost was significantly lower in the intervention group compared with the control group (\u221234.91\u20ac vs. \u22120.36\u20ac; <jats:italic>p<\/jats:italic> &amp;lt; 0.004).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Applying a PCP model improves pharmacotherapeutic indicators and reduces the costs associated with pharmacological treatment in hospitalized geriatric patients at the EOL, continuing for 3 months after hospital discharge. Future studies must investigate continuity in the transition between hospital care and primary care so that these new care models are offered transversally and not in isolation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.994819","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T05:42:00Z","timestamp":1664775720000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Application of a person-centered prescription model improves pharmacotherapeutic indicators and reduces costs associated with pharmacological treatment in hospitalized older patients at the end of life"],"prefix":"10.3389","volume":"10","author":[{"given":"Alexander","family":"Ferro-Uriguen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idoia","family":"Beobide-Telleria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gil-Goikouria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra Teresa","family":"Pe\u00f1a-Labour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"D\u00edaz-Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlovia Teresa","family":"Herasme-Grull\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Echevarr\u00eda-Orella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Seco-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-017-0860-2","article-title":"How many people will need palliative care in 2040? Past trends, future projections and implications for services","volume":"15","author":"Etkind","year":"2017","journal-title":"BMC Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e041317","DOI":"10.1136\/bmjopen-2020-041317","article-title":"How many people will need palliative care in Scotland by 2040? A mixed-method study of projected palliative care need and recommendations for service delivery","volume":"11","author":"Finucane","year":"2021","journal-title":"BMJ Open."},{"key":"B3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.eurger.2015.01.002","article-title":"Frailty, severity, progression and shared decision-making : a pragmatic framework for the challenge of clinical complexity at the end of life","volume":"6","author":"Ambl\u00e0s-Novellas","year":"2015","journal-title":"Eur Geriatr Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/pds.4956","article-title":"Evolution of polypharmacy in a spanish population (2005\u20132015): a database study","volume":"29","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","article-title":"An update on the clinical consequences of polypharmacy in older adults: a narrative review","volume":"17","author":"Wastesson","year":"2018","journal-title":"Expert Opin Drug Saf."},{"key":"B6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expert Opin Drug Saf."},{"key":"B7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2165\/11631740-000000000-00000","article-title":"Drug therapy optimization at the end of life","volume":"29","author":"Cruz-Jentoft","year":"2012","journal-title":"Drugs Aging."},{"key":"B8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/aging\/afr059","article-title":"Pharmacotherapy at the end-of-life","volume":"40","author":"O'mahony","year":"2011","journal-title":"Age Aging"},{"key":"B9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.amjmed.2017.02.028","article-title":"Choosing wisely? Measuring the burden of medications in older adults near the end of life: nationwide, longitudinal cohort study","volume":"130","author":"Morin","year":"2017","journal-title":"Am J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1177\/0269216319854013","article-title":"How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study","volume":"33","author":"Morin","year":"2019","journal-title":"Palliat Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1177\/0269216316676647","article-title":"Utility of the NECPAL CCOMS-ICO tool and the surprise question as screening tools for early palliative care and to predict mortality in patients with advanced chronic conditions: a cohort study","volume":"31","author":"G\u00f3mez-Batiste","year":"2017","journal-title":"Palliat Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jgs.13866","article-title":"Person-centered care: a definition and essential elements","volume":"64","year":"2016","journal-title":"J Am Geriatr Soc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1017\/S1463423616000207","article-title":"Person-centered medicines optimisation policy in England: an agenda for research on polypharmacy","volume":"18","author":"Heaton","year":"2017","journal-title":"Prim Heal Care Res Dev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e051238","DOI":"10.1136\/bmjopen-2021-051238","article-title":"Person-centered care provided by a multidisciplinary primary care team to improve therapeutic adequacy in polymedicated elderly patients (PCMR): randomized controlled trial protocol","volume":"12","author":"Rovira","year":"2022","journal-title":"BMJ Open"},{"key":"B15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.regg.2017.03.002","article-title":"Patient-centered prescription model to improve adequate prescription and therapeutic adherence in patients with multiple disorders","volume":"52","author":"Espaulella-Panicot","year":"2017","journal-title":"Rev Esp Geriatr Gerontol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/0140-6736(93)92884-V","article-title":"Comprehensive geriatric assessment: a meta-analysis of controlled trials","volume":"342","author":"Stuck","year":"1993","journal-title":"Lancet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/jgs.15616","article-title":"Tools for deprescribing in frail older persons and those with limited life expectancy: a systematic review","volume":"67","author":"Thompson","year":"2019","journal-title":"J Am Geriatr Soc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1111\/bcp.14113","article-title":"Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: a systematic review","volume":"86","author":"Shrestha","year":"2020","journal-title":"Br J Clin Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMp1113631","article-title":"Goal-oriented patient care-an alternative health outcomes paradigm","volume":"366","author":"Reuben","year":"2012","journal-title":"N Engl J Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.amjmed.2003.09.031","article-title":"The end of the disease era","volume":"116","author":"Tinetti","year":"2004","journal-title":"Am J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.medcli.2012.06.027","article-title":"Identification of people with chronic advanced diseases and need of palliative care in sociosanitary services: elaboration of the NECPAL CCOMS-ICO tool","volume":"140","author":"G\u00f3mez-Batiste","year":"2013","journal-title":"Med Clin (Barc)."},{"key":"B22","first-page":"434","article-title":"Evaluation of the reliability and validity of a scale of social evaluation of the elderly","volume":"23","author":"Vicente","year":"1999","journal-title":"Aten Primaria."},{"key":"B23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.regg.2016.09.003","article-title":"Frail-VIG index: design and evaluation of a new frailty index based on the comprehensive geriatric assessment","volume":"52","author":"Ambl\u00e0s-Novellas","year":"2016","journal-title":"Rev Esp Geriatr Gerontol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The global deterioration scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jpainsymman.2012.01.014","article-title":"The Spanish version of the edmonton symptom assessment system-revised (ESAS-r): first psychometric analysis involving patients with advanced cancer","volume":"20","author":"Carvajal Valc\u00e1rcel","year":"2013","journal-title":"J Pain Symptom Manag."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/0895-4356(92)90144-C","article-title":"A method for assesing drug therapy appropriateness","volume":"45","author":"Hanlon","year":"1992","journal-title":"J Clin Epidmiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/aging\/afx005","article-title":"STOPPFrail (screening tool of older persons prescriptions in frail adults with limited life expectancy): consensus validation","volume":"46","author":"Lavan","year":"2017","journal-title":"Age Aging."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1345\/aph.1D479","article-title":"Development validation of the medication regimen complexity index","volume":"38","author":"George","year":"2004","journal-title":"Ann Pharmacother."},{"key":"B31","unstructured":""},{"key":"B32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A drug burden index to define the functional burden of medications in older people","volume":"167","author":"Hilmer","year":"2007","journal-title":"Am Geriatr Soc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1477-7525-9-95","article-title":"Medication quality and quality of life in the elderly, a cohort study","volume":"9","author":"Nordin Olsson","year":"2011","journal-title":"Health Qual Life Outcomes."},{"key":"B34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/gerona\/glw140","article-title":"Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study","volume":"72","author":"Wallace","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0149984","article-title":"Deprescribing in frail older people: a randomized controlled trial","volume":"11","author":"Potter","year":"2016","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/PPA.S48357","article-title":"Identification of drug-related problems of elderly patients discharged from hospital","volume":"8","author":"Ahmad","year":"2014","journal-title":"Patient Prefer Adherence."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-019-3995-3","article-title":"patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial","volume":"19","author":"Vasilevskis","year":"2019","journal-title":"BMC Health Serv Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.healthpol.2017.09.006","article-title":"Multimorbidity care model: recommendations from the consensus meeting of the joint action on chronic diseases and promoting healthy aging across the life cycle (JA-CHRODIS)","volume":"122","author":"Palmer","year":"2018","journal-title":"Health Policy."},{"key":"B39","unstructured":"2003"},{"key":"B40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00228-021-03207-9","article-title":"Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity","volume":"78","author":"Gonz\u00e1lez-Bueno","year":"2022","journal-title":"Eur J Clin Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12877-022-03107-2","article-title":"Improving individualized prescription in patients with multimorbidity through medication review","volume":"22","author":"Molist-Brunet","year":"2022","journal-title":"BMC Geriatr."},{"key":"B42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00520-014-2322-0","article-title":"The development and evaluation of an oncological palliative care deprescribing guideline: the \u2018OncPal deprescribing guideline'","volume":"23","author":"Lindsay","year":"2015","journal-title":"Support Care Cancer."},{"key":"B43","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1089\/jpm.2020.0225","article-title":"Polypharmacy in palliative care: two deprescribing tools compared with a clinical review","volume":"24","author":"Mcneill","year":"2021","journal-title":"J Palliat Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s11606-014-2924-8","article-title":"Prescribing quality in older veterans: a multifocal approach","volume":"29","author":"Steinman","year":"2014","journal-title":"J Gen Intern Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/aging\/afaa159","article-title":"Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2","volume":"50","author":"Curtin","year":"2021","journal-title":"Age Aging."},{"key":"B46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00228-015-1974-0","article-title":"Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features","volume":"72","author":"Pedr\u00f3s","year":"2016","journal-title":"Eur J Clin Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ejim.2014.10.001","article-title":"Understanding adverse drug reactions in older adults through drug-drug interactions","volume":"25","author":"Marengoni","year":"2014","journal-title":"Eur J Intern Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"19711","DOI":"10.18632\/aging.104018","article-title":"Risk of hospitalization from drug-drug interactions in the elderly: real-world evidence in a large administrative database","volume":"12","author":"Swart","year":"2020","journal-title":"Aging."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2018-022500","article-title":"Anticholinergic and sedative drug burden in community-dwelling older people: a national database study","volume":"8","author":"Byrne","year":"2018","journal-title":"BMJ Open."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.mcna.2016.04.020","article-title":"Symptom control at the end of life","volume":"100","author":"Kreher","year":"2016","journal-title":"Med Clin North Am."},{"key":"B51","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jpainsymman.2016.03.020","article-title":"Anticholinergic drug burden in non-cancer vs cancer patients near the end of life","volume":"52","author":"Hochman","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"B52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0269216309102528","article-title":"Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches","volume":"23","author":"Agar","year":"2009","journal-title":"Palliat Med."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.994819\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T05:42:04Z","timestamp":1664775724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.994819\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":52,"alternative-id":["10.3389\/fpubh.2022.994819"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.994819","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"article-number":"994819"}}